Tao Synergies Inc. (TAOX)
NASDAQ · Finance, Insurance & Real Estate · Finance services
$4.43−$0.0418 (−0.94%) on the dayAs of the close; data may be delayed.
TAOX price, last 12 months
Key stats
- Previous close
- $4.47
- Open
- $4.57
- Day range
- $4.25 – $4.66
- 52-week range
- $3.07 – $10.00
- Volume
- 183.1K
- Avg volume (20 days)
- 234.7K
- Market cap
- $33.2M
Performance
1W−3.1%
1M+11.0%
3M+23.7%
6M−21.1%
YTD+20.3%
1Y−25.7%
vs S&P 500, 1Y−42.5 pts
Technicals and fundamentals
About Tao Synergies Inc.
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
- Sector
- Finance, Insurance & Real Estate
- Industry
- Finance services
- Listed on
- NASDAQ
- Market cap
- $33.2M